Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ELI LILLY AND COMPANY v. VALEANT PHARMACEUTICALS INTERNATIONAL
Case Number:
1:08-cv-01720
Court:
Nature of Suit:
195(Contract Product Liability)
Judge:
Firms
Companies
Sectors & Industries:
-
February 15, 2011
Valeant Must Share In Lilly Defense Costs, Judge Says
A federal judge has determined that an agreement requires Valeant Pharmaceuticals International Inc. to assume full cost-sharing obligations, including the payment of all defense costs, in product liability cases involving Eli Lilly & Co.'s discontinued Parkinson's drug Permax.
-
December 29, 2008
Lilly Clashes With Valeant Over Permax Liability Costs
As Eli Lilly and Co. faces product liability claims over its discontinued drug Permax, the drugmaker has sued Valeant Pharmaceuticals International to force the bridling licensee to shoulder its share of costs associated with litigation.